NCT04326894View on ClinicalTrials.gov

Methorexate and Knee Osteoarthritis

PHASE4CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Pain ReductionPhysical Function Improvement
Interventions
DRUG

25 mg/week oral methotrexate tablets

DRUG

25mg/week oral placebo tablets

Trial Locations (1)

00203

Faculty of Medicine, Alexandria

All Listed Sponsors
lead

University of Alexandria

OTHER

NCT04326894 - Methorexate and Knee Osteoarthritis | Biotech Hunter | Biotech Hunter